Inside Drug Pricing - 02/04/2019

Ranking Oversight Republican Wants To Reform Drug Patent Law

By John Wilkerson
January 30, 2019 at 1:54 PM
The ranking Republican on the House oversight committee said Tuesday (Jan. 29) that he would like to work with Democrats to stop drug makers from abusing patents and exclusivity periods. Both parties, and the administration, want to take action that would bring down drug prices, but which policies they might work together on remains unclear. Senate Finance Committee Chair Chuck Grassley (R-IA), for instance, opposes Medicare price negotiation, which is a key part of Democrats’ platform on lowering drug prices,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.